Targinta AB
559157-6698ActiveDeveloping targeted antibodies and ADCs for aggressive cancers.
Översikt
- 0
- Anställda
- ≤1t SEK
- Omsättning
- 2018
- Grundat
Nyckelbeslutsfattare
Evy Lundgren-Åkerlund
CEO
Beskrivning
Targinta AB is a Swedish biotechnology company focused on developing novel treatments for aggressive and life-threatening cancers. The company specializes in creating targeted, toxin-armed antibodies, known as Antibody-Drug Conjugates (ADCs), and functional blocking antibodies. Their entire product...
Taggar
Nyckelord
Teknikstack
Företagsinformation
- Bransch
- Bioteknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- Momsnummer
- SE559157669801
Beslutsfattare
1 kontakter i FunnelfeedrEvy Lundgren-Åkerlund
CEO
Liknande företag
20 liknande företag i FunnelfeedrXintela AB
10–19 anställdaDeveloping stem cell and targeted cancer therapies for unmet needs.
Ascelia Pharma AB
Biotech developing novel orphan oncology drugs for unmet needs.
BioInvent International Aktiebolag
100–199 anställdaClinical-stage company developing novel immuno-oncology antibody therapeutics for cancer.
Ascelia Incentive AB
Biotech developing novel orphan oncology drugs for unmet medical needs.
Affibody Medical AB
Developing next-generation radiopharmaceuticals using proprietary Affibody platform.
Utforska mer
Frågor om Targinta AB
Vill du se Funnelfeedr i praktiken?
Boka en gratis demo och upptäck hur Funnelfeedr hjälper dig att hitta och konvertera dina idealkunder.
Boka en demo